tiprankstipranks

Deepa Prasad Insider Profile

4 Followers
Deepa Prasad, Director at Design Therapeutics, holds 20.00K shares in Design Therapeutics (Ticker: DSGN), holds ― shares in vTv Therapeutics (Ticker: VTVT). Most recently, Deepa Prasad Sold ― shares of Design Therapeutics on Dec 19, 2024 for an estimated value of 23.86K.
tipranks
Deepa Prasad

Deepa Prasad
Design Therapeutics (DSGN)
Director

Ranked #30,839 out of 100,202 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

+50.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$125K
100.00%
0.00%
A breakdown of Deepa Prasad's holdings

Insider Roles

Design Therapeutics
(DSGN)
Director
vTv Therapeutics
(VTVT)
President and CEO, Director
Roles that Deepa Prasad holds in companies

Most Profitable Insider Trade

Stock:
Design Therapeutics
(DSGN)
Rating:Informative Buy
Date:Aug 30, 2023 - Aug 30, 2024
Return:+104.70%
The most profitable trade made by Deepa Prasad

Deepa Prasad's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Design Therapeutics
Dec 19, 2024
Director
Informative Sell
23.86K
$125.00K
vTv Therapeutics
President and CEO, Director
List of latest transactions for each holding click on a transaction to see Deepa Prasad's performance on stock

Deepa Prasad insider profile FAQ

What is the percentage of profitable transactions made by Deepa Prasad?
The percentage of profitable transactions made by Deepa Prasad is 50%.
    What is the average return per transaction made by Deepa Prasad?
    The average return per transaction made by Deepa Prasad is 50.20%.
      What stocks does Deepa Prasad hold?
      Deepa Prasad holds: DSGN, VTVT stocks.
        What was Deepa Prasad’s latest transaction?
        Deepa Prasad latest transaction was an Informative Sell of $23.86K.
          What was Deepa Prasad's most profitable transaction?
          Deepa Prasad’s most profitable transaction was an Informative Buy of DSGN stock on August 30, 2023. The return on the trade was 104.70%.
            What is Deepa Prasad's role in Design Therapeutics?
            Deepa Prasad's role in Design Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.